Skip to search formSkip to main contentSkip to account menu

Triptans

Derivatives of TRYPTAMINES that are SEROTONIN RECEPTOR AGONISTS acting at 5-HT1 RECEPTORS. Some are used to treat MIGRAINE DISORDERS.
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Serotonin 5-HT1 Receptor AgonistsTryptamines

Narrower (1)

Sumatriptan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
New therapeutic approaches for the prevention and treatment of migraine
Review
2012
Review
2012
Rescue Therapy for Acute Migraine, Part 3: Opioids, NSAIDs, Steroids, and Post‐Discharge Medications
Objective.— The final section of this 3‐part review analyzes published reports involving the acute treatment of migraine with… 
Highly Cited
2009
Highly Cited
2009
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study.
Migraine headache is widely believed to be associated with cerebral or meningeal vasodilatation. Human evidence for this… 
Review
2006
Review
2006
5-hydroxytryptamine receptors in the human cardiovascular system.
Highly Cited
2004
Highly Cited
2004
Analgesic triptan action in an animal model of intracranial pain: A race against the development of central sensitization
We have shown that the development of cutaneous allodynia (exaggerated skin sensitivity) during migraine is detrimental to the… 
Review
2004
Review
2004
Calcitonin gene-related peptide and its role in migraine pathophysiology.
Review
2004
Review
2004
French guidelines for the diagnosis and management of migraine in adults and children.
Highly Cited
2001
Highly Cited
2001
Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial
Highly Cited
2000
Highly Cited
2000
Triptans in Migraine
Triptans are a new class of compounds developed for the treatment of migraine attacks. The first of the class, sumatriptan, and… 
Review
1999
Review
1999
Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)